Taylor Wealth Management Partners Galera Therapeutics, Inc. Transaction History

Taylor Wealth Management Partners

  • $176 Million
  • Q2 2022

A detailed history of Taylor Wealth Management Partners transactions in Galera Therapeutics, Inc. stock. As of the latest transaction made, Taylor Wealth Management Partners holds 10,700 shares of GRTX stock, worth $321. This represents 0.01% of its overall portfolio holdings.

Number of Shares
10,700
Previous 11,635 8.04%
Holding current value
$321
Previous $28,000 50.0%
% of portfolio
0.01%
Previous 0.01%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$1.24 - $2.39 $1,159 - $2,234
-935 Reduced 8.04%
10,700 $14,000
Q4 2021

Jan 28, 2022
SELL
$1.27 - $8.28 $58,898 - $384,001
-46,377 Reduced 79.94%
11,635 $53,000
Q3 2021

Oct 26, 2021
SELL
$7.04 - $10.49 $50,547 - $75,318
-7,180 Reduced 11.01%
58,012 $470,000
Q2 2021

Aug 11, 2021
BUY
$6.08 - $10.44 $1,276 - $2,192
210 Added 0.32%
65,192 $641,000
Q1 2021

Apr 21, 2021
BUY
$8.35 - $12.39 $1,912 - $2,837
229 Added 0.35%
64,982 $573,000
Q4 2020

Feb 02, 2021
BUY
$8.02 - $12.81 $20,707 - $33,075
2,582 Added 4.15%
64,753 $662,000
Q3 2020

Oct 14, 2020
BUY
$6.96 - $9.12 $15,597 - $20,437
2,241 Added 3.74%
62,171 $562,000
Q2 2020

Jul 27, 2020
BUY
$7.14 - $14.41 $427,900 - $863,591
59,930 New
59,930 $428,000

Others Institutions Holding GRTX

# of Institutions
2
Shares Held
909K
Call Options Held
0
Put Options Held
0
View Full List

About Galera Therapeutics, Inc.

GRTX Quotes by TradingView
  • Ticker GRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,821,600
  • Market Cap $805K
  • Description
  • Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...
More about GRTX
Track This Portfolio

Track Taylor Wealth Management Partners Portfolio

Follow Taylor Wealth Management Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Taylor Wealth Management Partners, based on Form 13F filings with the SEC.

News

Stay updated on Taylor Wealth Management Partners with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email